Annexon, Inc. (ANNX) stock
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.47−0.10 (-2.80%)
Close on Nov 17, 2026Market cap $709.42MP/E –Yield 0.00%
Annexon cash
Cash and short-term investments held at the end of each period.
Annexon's cash was $209.20M at Jun 30, 2026. For fiscal 2025 it was $238.30M, down 23.6% from the year before. The highest annual figure on record is $351.20M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $238.30M | -23.6% |
| FY2024 | Dec 31, 2024 | $312.00M | +20.1% |
| FY2023 | Dec 31, 2023 | $259.70M | +7.0% |
| FY2022 | Dec 31, 2022 | $242.70M | 0.0% |
| FY2021 | Dec 31, 2021 | $242.70M | -30.9% |
| FY2020 | Dec 31, 2020 | $351.20M | +699.4% |
| FY2019 | Dec 31, 2019 | $43.93M | -0.6% |
| FY2018 | Dec 31, 2018 | $44.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $209.20M | -7.8% |
| Q1 FY2026 | Mar 31, 2026 | $225.00M | -14.7% |
| Q4 FY2025 | Dec 31, 2025 | $238.30M | -23.6% |
| Q3 FY2025 | Sep 30, 2025 | $188.70M | -44.5% |
| Q2 FY2025 | Jun 30, 2025 | $227.00M | -38.4% |
| Q1 FY2025 | Mar 31, 2025 | $263.70M | -0.5% |
| Q4 FY2024 | Dec 31, 2024 | $312.00M | +20.1% |
| Q3 FY2024 | Sep 30, 2024 | $340.10M | +105.7% |
| Q2 FY2024 | Jun 30, 2024 | $368.70M | +91.1% |
| Q1 FY2024 | Mar 31, 2024 | $264.90M | +16.1% |
| Q4 FY2023 | Dec 31, 2023 | $259.70M | +7.0% |
| Q3 FY2023 | Sep 30, 2023 | $165.30M | -38.7% |
| Q2 FY2023 | Jun 30, 2023 | $192.90M | +8.6% |
| Q1 FY2023 | Mar 31, 2023 | $228.20M | +10.4% |
| Q4 FY2022 | Dec 31, 2022 | $242.70M | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $269.50M | -0.7% |
| Q2 FY2022 | Jun 30, 2022 | $177.60M | -41.3% |
| Q1 FY2022 | Mar 31, 2022 | $206.70M | -36.7% |
| Q4 FY2021 | Dec 31, 2021 | $242.70M | -30.9% |
| Q3 FY2021 | Sep 30, 2021 | $271.40M | -26.8% |
| Q2 FY2021 | Jun 30, 2021 | $302.40M | +142.4% |
| Q1 FY2021 | Mar 31, 2021 | $326.70M | +879.7% |
| Q4 FY2020 | Dec 31, 2020 | $351.20M | +699.4% |
| Q3 FY2020 | Sep 30, 2020 | $370.69M | +590.8% |
| Q2 FY2020 | Jun 30, 2020 | $124.76M | +296.7% |
| Q1 FY2020 | Mar 31, 2020 | $33.35M | -24.5% |
| Q4 FY2019 | Dec 31, 2019 | $43.93M | – |
| Q3 FY2019 | Sep 30, 2019 | $53.66M | – |
| Q2 FY2019 | Jun 30, 2019 | $31.45M | – |
| Q4 FY2018 | Dec 31, 2018 | $44.18M | – |
See a number that looks wrong?